Biotech, Pharma Stocks Surge as IPAB Not Triggered

As noted earlier, biotech and pharmaceutical stocks surged higher mid-day on news the Medicare IPAB cost panel was not triggered this year, pushing it into 2017.

Related Stocks:

• Amgen (NASDAQ: AMGN)
• Biogen (NASDAQ: BIIB)
• Celgene (NASDAQ: CELG)
• iShares Nasdaq Biotechnology (NASDAQ: IBB)
• Regeneron (NASDAQ: REGN)
• SPDR S&P Biotech ETF (NYSE: XBI)
• Gilead Sciences (NASDAQ: GILD)
• Pfizer (NYSE: PFE)
• Allergan (NYSE: AGN)
• Valeant Pharma (NYSE: VRX)
• Merck (NYSE: MRK)
• Endo Int'l (NASDAQ: ENDP)

You May Also Be Interested In

• Honeywell Aerospace to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600
• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• SEC probing popular type of private equity fund as it steps up industry scrutiny - Reuters